Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 2c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q3 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Walmart expands pharmacy support for Medicare GLP-1 coverage
• Buy gold stocks as valuations are cheap amid macro tension: BofA